The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reduction in Curie score in neuroblastoma patients treated with naxitamab.
 
Jaume Mora
Consulting or Advisory Role - YmAbs Therapeutics Inc
Patents, Royalties, Other Intellectual Property - YmAbs Therapeutics Inc
 
Godfrey Chi-Fung Chan
Leadership - Xellera Therapeutics
Stock and Other Ownership Interests - Xellera Therapeutics
Consulting or Advisory Role - Xellera Therapeutics
Patents, Royalties, Other Intellectual Property - The University of Hong Kong
 
Daniel A. Morgenstern
Consulting or Advisory Role - Oncoheroes Biosciences; RayzeBio; Regeneron; YmAbs Therapeutics Inc
 
Loredana Amoroso
No Relationships to Disclose
 
Karsten Nysom
Honoraria - Y-mAbs Therapeutics
Consulting or Advisory Role - Bayer; EUSA Pharma; Lilly; Ymabs Therapeutics Inc
 
Joerg Faber
Research Funding - YmAbs Therapeutics Inc
 
Arthur Wingerter
Honoraria - YmAbs Therapeutics Inc
Consulting or Advisory Role - EUSA Pharma
 
Melissa Bear
Honoraria - Y-mAbs Therapeutics
 
Alba Rubio-San-Simón
Honoraria - EUSA Pharma; Sanofi
Consulting or Advisory Role - EUSA Pharma; Sanofi
Speakers' Bureau - EUSA Pharma
 
Brian H. Kushner
No Relationships to Disclose
 
Karen Tornøe
Employment - YmAbs Therapeutics Inc
Stock and Other Ownership Interests - YmAbs Therapeutics Inc
 
Rene DePont Christensen
Employment - YmAbs Therapeutics Inc
Stock and Other Ownership Interests - YmAbs Therapeutics Inc